Document is current
Any future updates will be listed below
-
Authors
Sparling, Kennedy
Butler, Daniel C.
- License Information
-
More Information
Article History
Accepted: 12 August 2024
First Online: 16 September 2024
Declarations
:
: Daniel C. Butler is a consultant for Galderma and Sanofi. Kennedy Sparling has no conflicts of interest to declare that may be relevant to the contents of this article.
: Not applicable.
: Not applicable.
: No sources of funding were received to assist in the preparation of this article.
: Not applicable.
: KS: writing—original draft preparation, writing—review and editing. DCB: conceptualization, validation, review and editing. Both authors read and approved the final version of the manuscript.
